RT Journal
A1 Ho P, Rumsfeld JS, Wang L
T1 ADverse outcomes associated with use of proton pump inhibitors and clopidogrel—reply
JF JAMA
JO JAMA
YR 2009
FD July 1
VO 302
IS 1
SP 29
OP 31
DO 10.1001/jama.2009.900
UL http://dx.doi.org/10.1001/jama.2009.900
AB 
Chae and Kim cite the ACCF/ACG/AHA consensus statement on reducing gastrointestinal risks of antiplatelet therapy and NSAID use. This statement recommended that patients taking dual antiplatelet therapy should be prescribed a PPI medication in the presence of specific risk factors.1